Global Antisera Market 2024

Antisera Market Size

In 2021, after two years of growth, there was significant decline in the global antisera market, when its value decreased by -8.3% to $X. The market value increased at an average annual rate of +2.0% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. Over the period under review, the global market attained the maximum level at $X in 2020, and then declined in the following year.

Antisera Production

In value terms, antisera production expanded rapidly to $X in 2021 estimated in export price. Over the period under review, production showed strong growth. The most prominent rate of growth was recorded in 2017 with an increase of 70%. Over the period under review, global production attained the peak level at $X in 2019; however, from 2020 to 2021, production remained at a lower figure.

Antisera Exports

Exports

In 2021, approx. X tons of antisera and other blood fractions were exported worldwide; jumping by 63% against the previous year. Over the period under review, exports enjoyed a prominent increase. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, antisera exports totaled $X in 2021. Overall, exports saw buoyant growth. The most prominent rate of growth was recorded in 2020 with an increase of 28% against the previous year. Over the period under review, the global exports reached the maximum in 2021 and are expected to retain growth in years to come.

Exports by Country

China was the key exporter of antisera and other blood fractions in the world, with the volume of exports accounting for X tons, which was approx. 44% of total exports in 2021. The United States (X tons) ranks second in terms of the total exports with a 14% share, followed by Germany (7.4%). The following exporters - Spain (X tons), the Netherlands (X tons), Austria (X tons), the UK (X tons), Turkey (X tons), Belgium (X tons), Switzerland (X tons) and France (X tons) - together made up 23% of total exports.

China was also the fastest-growing in terms of the antisera and other blood fractions exports, with a CAGR of +45.6% from 2012 to 2021. At the same time, Turkey (+43.1%), the Netherlands (+40.3%), France (+16.5%), Belgium (+16.4%), Austria (+14.2%), Spain (+9.6%), Germany (+9.2%), Switzerland (+8.4%) and the United States (+7.3%) displayed positive paces of growth. The UK experienced a relatively flat trend pattern. From 2012 to 2021, the share of China, the Netherlands and Turkey increased by +38, +3.2 and +1.9 percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest antisera supplying countries worldwide were Switzerland ($X), Germany ($X) and the United States ($X), with a combined 46% share of global exports. Belgium, the Netherlands, China, Austria, the UK, France, Spain and Turkey lagged somewhat behind, together accounting for a further 27%.

Among the main exporting countries, Turkey, with a CAGR of +71.9%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Export Prices by Country

The average antisera export price stood at $X per ton in 2021, waning by -29.3% against the previous year. Overall, the export price showed a slight shrinkage. The growth pace was the most rapid in 2017 when the average export price increased by 17%. The global export price peaked at $X per ton in 2020, and then contracted sharply in the following year.

Prices varied noticeably country of origin: the country with the highest price was Switzerland ($X per ton), while China ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Turkey (+20.1%), while the other global leaders experienced more modest paces of growth.

Antisera Imports

Imports

In 2021, overseas purchases of antisera and other blood fractions increased by 53% to X tons, rising for the fifth consecutive year after two years of decline. Overall, imports enjoyed buoyant growth. As a result, imports reached the peak and are likely to continue growth in the immediate term.

In value terms, antisera imports skyrocketed to $X in 2021. Over the period under review, imports showed a strong expansion. The pace of growth was the most pronounced in 2017 when imports increased by 24%. Over the period under review, global imports attained the peak figure in 2021 and are likely to continue growth in the near future.

Imports by Country

In 2021, Germany (X tons), distantly followed by Austria (X tons), Canada (X tons), the Netherlands (X tons), the United States (X tons) and France (X tons) represented the key importers of antisera and other blood fractions, together comprising 54% of total imports. China (X tons), Italy (X tons), Ireland (X tons), Australia (X tons), Belgium (X tons), Mexico (X tons) and Spain (X tons) took a relatively small share of total imports.

Imports into Germany increased at an average annual rate of +19.1% from 2012 to 2021. At the same time, Ireland (+55.0%), the Netherlands (+32.6%), Australia (+23.8%), the United States (+18.2%), France (+16.9%), Austria (+16.6%), China (+16.2%), Belgium (+13.4%), Italy (+9.7%), Mexico (+7.4%), Spain (+4.3%) and Canada (+2.0%) displayed positive paces of growth. Moreover, Ireland emerged as the fastest-growing importer imported in the world, with a CAGR of +55.0% from 2012-2021. While the share of Germany (+7.8 p.p.), the Netherlands (+5.7 p.p.), the United States (+2.8 p.p.), Austria (+2.7 p.p.), Ireland (+2.6 p.p.), France (+1.6 p.p.) and Australia (+1.5 p.p.) increased significantly in terms of the global imports from 2012-2021, the share of Spain (-1.5 p.p.) and Canada (-10.2 p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the United States ($X), Germany ($X) and Belgium ($X) constituted the countries with the highest levels of imports in 2021, with a combined 42% share of global imports. These countries were followed by China, the Netherlands, France, Italy, Austria, Canada, Spain, Ireland, Australia and Mexico, which together accounted for a further 28%.

Among the main importing countries, Ireland, with a CAGR of +45.4%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices by Country

The average antisera import price stood at $X per ton in 2021, waning by -24.2% against the previous year. In general, import price indicated a slight increase from 2012 to 2021: its price increased at an average annual rate of +1.9% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2016 when the average import price increased by 16% against the previous year. Over the period under review, average import prices reached the maximum at $X per ton in 2020, and then declined significantly in the following year.

Prices varied noticeably country of destination: the country with the highest price was the United States ($X per ton), while Mexico ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the Netherlands (+8.6%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :